Discover how DermaClose helps
surgeons improve outcomes.



Can DermaClose make surgery
less invasive for you?

Orthopedic and trauma surgeons use DermaClose to help them achieve primary
closure, avoid skin grafts and donor sites, and improve outcomes in
surgeries such as:icon3

  • Large, tissue loss injuries
  • Open fractures
  • Faciotomy repair
  • Amputation wound closure
  • Post-surgical wound infections
  • Infected hardware removal
  • Wound dehiscence
  • Post trauma (non closable wounds)

DermaClose gives plastic surgeons a tool to use their creativity when treating their challenging wounds. Many plastic surgeons have told us they use DermaClose as a creative tool. Applications include:icon2

  • Fasciotomy repair
  • ALT donor site wound closure
  • Trauma
  • Wound dehiscence
  • Oncologic excisions
  • Complex, non-healing wounds
  • Scar revisionss

From large, open abdomens to wound dehiscence, DermaClose is a proven option
for general surgeons who need an effective and fast way to close large open wounds
while avoiding skin grafts. Applications include:icon1

  • Open abdomen
  • Large skin excisions (cancer)
  • Post trauma (non-closeable wounds)
  • Wound dehiscence
  • Fasciotomy repair
  • Amputation wound closure
  • Scalp excision

DermaClose has been used extensively in foot and ankle surgery with a track record
of clinical success. Foot and ankle surgeons and podiatrists use it for:icon4

  • Diabetic foot ulcers
  • Post incision and drainage wound repair
  • Trans-metatarsal amputation (TMA)
  • Ray amputations
  • Achilles tendon repairs
  • Infected hardware removal
  • Calcenectomies
  • Scar revisions

Vascular surgeons have also used DermaClose as part of their surgical
armamentarium for:icon5

  • Lower leg bypass graft surgeries (open graft)
  • Leg vessel graft procedures (fem-pop)
  • Amputation
  • Wound dehiscence
  • Diabetic foot ulcer repair
  • Non-healing wounds

Clinical benefits

  • Reduces time to closure.
    • In a study at Walter Reed in 14 blast victims with significant tissue trauma, DermaClose achieved delayed primary closure within 4.4 days in 86% of patients in wounds averaging 263 cm squared
  • Proven in multiple surgical specialties and applications
  • Helps avoid skin grafts, donor sites, and associated risks and complications
  • Quickly becoming a standard of care for fasciotomy wounds
  • Reduces time to closure, surgical complexity, and risk of open wound complications
  • Improves surgical outcomes, cosmesis, and patient satisfaction
View Reimbursement Information Dermaclose QRG_11DR.pdf-1Download Quick Reference Guide

Case Reports